ID
35866
Description
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01992952
Link
https://clinicaltrials.gov/show/NCT01992952
Keywords
Versions (1)
- 3/29/19 3/29/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
March 29, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
fulvestrant | Phosphatidylinositide 3-Kinase Inhibitor | mTOR Inhibitor | AKT1 gene Inhibitor | AKT2 gene Inhibitor | AKT3 gene Inhibitor
Data type
boolean
Alias
- UMLS CUI [1]
- C0935916
- UMLS CUI [2]
- C1519050
- UMLS CUI [3]
- C2746052
- UMLS CUI [4,1]
- C0812228
- UMLS CUI [4,2]
- C1999216
- UMLS CUI [5,1]
- C0812230
- UMLS CUI [5,2]
- C1999216
- UMLS CUI [6,1]
- C1332074
- UMLS CUI [6,2]
- C1999216
Description
Glucose metabolism abnormal
Data type
boolean
Alias
- UMLS CUI [1]
- C1142273
Description
Disease Visceral Rapidly progressive | Hormone Therapy Inappropriate
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0442045
- UMLS CUI [1,3]
- C1838681
- UMLS CUI [2,1]
- C0279025
- UMLS CUI [2,2]
- C1548788
Description
Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
- UMLS CUI [2]
- C1704231
Description
Comorbidity Study Subject Participation Status Excluded | Heart Disease Significant
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C0332196
- UMLS CUI [2,1]
- C0018799
- UMLS CUI [2,2]
- C0750502
Description
Pharmaceutical Preparations Inappropriate Combination Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1548788
- UMLS CUI [1,3]
- C0205195
- UMLS CUI [1,4]
- C0013230
Similar models
Eligibility Estrogen Receptor Positive Breast Cancer NCT01992952
- StudyEvent: Eligibility
C1548788 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
C0679246 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
C0728940 (UMLS CUI [2,4])
C1334988 (UMLS CUI [2])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0593802 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C0593802 (UMLS CUI [2,1])
C0677850 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C0346993 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0680854 (UMLS CUI [1,2])
C0680854 (UMLS CUI [1,2])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
C0279025 (UMLS CUI [1,2])
C1519050 (UMLS CUI [2])
C2746052 (UMLS CUI [3])
C0812228 (UMLS CUI [4,1])
C1999216 (UMLS CUI [4,2])
C0812230 (UMLS CUI [5,1])
C1999216 (UMLS CUI [5,2])
C1332074 (UMLS CUI [6,1])
C1999216 (UMLS CUI [6,2])
C0442045 (UMLS CUI [1,2])
C1838681 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C1704231 (UMLS CUI [2])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0018799 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
C1548788 (UMLS CUI [1,2])
C0205195 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])